Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06214936 · ClinicalTrials.gov registry record · NA

Validating Incubators in the Lab: Optimizing Culture and Investigating blasTulation Yield

A NA study of Infertility, sponsored by Reproductive Medicine Associates of New Jersey.

Recruiting
Registry status
NA
Development phase
252
Enrollment target
1
Study location

NCT06214936: Recruiting NA study of Infertility, sponsored by Reproductive Medicine Associates of New Jersey.

NCT06214936 is a NA study of Infertility that is actively recruiting participants, run by Reproductive Medicine Associates of New Jersey. The registered enrollment target is 252 participants, below the 7,586-participant average among 74 other Infertility trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06214936, a NA study of Infertility, is actively recruiting participants, sponsored by Reproductive Medicine Associates of New Jersey.

RECRUITING
Registry status
NA
Development phase
252 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to determine if benchtop incubators improve the number of embryos making it to the blastocyst stage of development (about 4-6 days after fertilization) in people undergoing in vitro fertilization (IVF) treatment for their infertility. * Test the effectiveness of the benchtop incubator. * Determine if the number of embryos reaching the blastocyst stage of embryo development (the stage that the embryos are biopsied for PGT-A and frozen) is improved in the benchtop incubator compared to the box incubator. * Compare embryology outcomes between the two incubator types. * Investigate transfer and pregnancy outcomes. * Expand the knowledge surrounding the impact of the incubator on IVF outcomes. Patients will have their mature oocytes collected at the egg retrieval procedure split into two groups and randomized to be cultured in both incubator types.

Primary Outcome

count of blastocyst stage embryos per M2 count

Conditions Studied

Interventions

  • OTHER Benchtop Incubator
  • OTHER Box Incubator

Study Locations (1)

New Jersey

  • Reproductive Medicine Associates of New Jersey - Basking Ridge

Trial Details

FieldValue
Enrollment Target 252 participants
Start Date 2023-12-19
Est. Completion 2026-06
Phase NA

What NCT06214936 shows while recruiting

NCT06214936 is an interventional study that assigns participants to a tested intervention. The registered 252 participants enrollment target is mid-sized for trials with a published cap, below the 7,586-participant average among 74 other Infertility trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Infertility appearing as the primary indexed condition, and to 2 interventions - of which Benchtop Incubator is the first listed.

NCT06214936 reports a single indexed study location in New Jersey.

Frequently Asked Questions

What is clinical trial NCT06214936 about?

NCT06214936 is a clinical study titled "Validating Incubators in the Lab: Optimizing Culture and Investigating blasTulation Yield". The goal of this study is to determine if benchtop incubators improve the number of embryos making it to the blastocyst stage of development (about 4-6 days after fertilization) in people undergoing in vitro fertilization (IVF) treatment for their infertility. * Test the effectiveness of the bencht...

What is the current status of trial NCT06214936?

This trial is currently recruiting. It is a NA study. The enrollment target is 252 participants. The study started on 2023-12-19. Estimated completion is 2026-06.

What conditions does trial NCT06214936 study?

This clinical trial studies the following conditions: Infertility.

What interventions are being tested in trial NCT06214936?

The interventions under investigation include: Benchtop Incubator (OTHER), Box Incubator (OTHER).

Who is sponsoring clinical trial NCT06214936?

This trial is sponsored by Reproductive Medicine Associates of New Jersey, which has 51 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06214936 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infertility

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06214936's enrollment target sits among peer trials

252 36th of 74 higher than 39 of 74 other Infertility trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Infertility trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02314988 · 252 participants · Phase 2

    Tranexamic Acid to Reduce Blood Loss in Spine Surgery

  • NCT03941756 · 252 participants · NA

    Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma

  • NCT05219617 · 252 participants · Phase 3

    Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults

  • NCT05384158 · 252 participants · NA

    Valuation in Depressed Mood, Anhedonia, and Anxiety

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06214936, the US trial registry maintained by the National Library of Medicine. NCT06214936 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.